(Q36547710)

14 August 2017

1 reference

title

Two decades of cancer genetics: from specificity to pleiotropic networks (English)

1 reference

14 August 2017

1 reference

Grisendi S

1

1 reference

14 August 2017

Pandolfi PP

series ordinal

2

1 reference

14 August 2017

publication date

1 January 2005

1 reference

Cold Spring Harbor Symposia on Quantitative Biology

14 August 2017

published in

1 reference

14 August 2017

volume

70

1 reference

14 August 2017

page(s)

83-91

1 reference

Nucleophosmin/B23, a nuclear PI(3,4,5)P(3) receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Conditionally MYC: insights from novel transgenic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Ubiquitin-dependent degradation of p73 is inhibited by PML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Nucleophosmin regulates the stability and transcriptional activity of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Role of nucleophosmin in embryonic development and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

The function of PML in p53-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

PML protein isoforms and the RBCC/TRIM motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Hypoxia-induced nucleophosmin protects cell death through inhibition of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Causal relationship between the loss of RUNX3 expression and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Cytoplasmic PML function in TGF-beta signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

MYC oncogenes and human neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Atmospheric carbon dioxide concentrations over the past 60 million years

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Role of promyelocytic leukemia (PML) protein in tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

The role of PML in tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Preferential cleavage in pre-ribosomal RNA byprotein B23 endoribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

B23/nucleophosmin serine 4 phosphorylation mediates mitotic functions of polo-like kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

The transcriptional role of PML and the nuclear body

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FSQB.2005.70.023

21 January 2018

Identifiers

DOI

10.1101/SQB.2005.70.023

1 reference

14 August 2017

1 reference